These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37915198)

  • 1. [Heart disease in hemodialysis: physiopathology and therapeutic breakthroughs].
    Mercadal L; Boffa JJ; Collet JP
    Nephrol Ther; 2023 Nov; 19(6):542-551. PubMed ID: 37915198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based cardiology in hemodialysis patients.
    Allon M
    J Am Soc Nephrol; 2013 Dec; 24(12):1934-43. PubMed ID: 24136920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.
    McCullough PA; Chan CT; Weinhandl ED; Burkart JM; Bakris GL
    Am J Kidney Dis; 2016 Nov; 68(5S1):S5-S14. PubMed ID: 27772643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cardiovascular mortality in hemodialysis versus peritoneal dialysis.
    Ng CH; Ong ZH; Sran HK; Wee TB
    Int Urol Nephrol; 2021 Jul; 53(7):1363-1371. PubMed ID: 33113084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular hypertrophy is a risk factor independent of hypertension in survival of hemodialyzed patients.
    Nakamura S; Sasaki O; Nakahama H; Inenaga T; Kimura G
    Ren Fail; 2002 Mar; 24(2):175-86. PubMed ID: 12071591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electron beam tomography to image cardiovascular calcifications in hemodialysis patients.
    Raggi P
    J Nephrol; 2002; 15 Suppl 6():S77-81. PubMed ID: 12515377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular complications in patients with diabetic nephropathy receiving pharmacological versus renal replacement therapy.
    Głowińska I; Grochowski J; Małyszko J
    Pol Arch Med Wewn; 2008; 118(7-8):404-12. PubMed ID: 18714735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiovascular complication of renal dialysis. 2. Changes in the cardiovascular system in patients treated with periodic hemodialysis].
    de Belsunce M; Barnay C; Kessali V
    Rev Med Interne; 1981; 2(2):159-66. PubMed ID: 7020030
    [No Abstract]   [Full Text] [Related]  

  • 9. [Arterial hypertension and mortality due to cardiovascular complications in patients on chronic hemodialysis].
    Deschamps A; Grunfeld JP; Drueke T; Zingraff J; Jungers P
    Arch Mal Coeur Vaiss; 1978 Jul; 71 Spec No():25-9. PubMed ID: 101177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral disease in adults treated with hemodialysis: prevalence, predictors, and association with mortality and adverse cardiovascular events: the rationale and design of the ORAL Diseases in hemodialysis (ORAL-D) study, a prospective, multinational, longitudinal, observational, cohort study.
    Strippoli GF; Palmer SC; Ruospo M; Natale P; Saglimbene V; Craig JC; Pellegrini F; Petruzzi M; De Benedittis M; Ford P; Johnson DW; Celia E; Gelfman R; Leal MR; Torok M; Stroumza P; Bednarek-Skublewska A; Dulawa J; Frantzen L; Ferrari JN; del Castillo D; Hegbrant J; Wollheim C; Gargano L;
    BMC Nephrol; 2013 Apr; 14():90. PubMed ID: 23597063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac consequences of hypertension in hemodialysis patients.
    Zoccali C; Benedetto FA; Tripepi G; Mallamaci F
    Semin Dial; 2004; 17(4):299-303. PubMed ID: 15250922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of renal transplantation on the cardiac function of patients with hemodialysis.
    Takahashi K; Ikeoka K; Nojima M; Shima H; Ohyanagi M
    J Cardiol; 2007 Jan; 49(1):23-9. PubMed ID: 17269210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The lipid model in hemodialyzed patients].
    Navino C; Zamboni G; Barbè MC; Guida GE; Ruva CE; De Leo M; Cusaro C; Pecora S; Chiarinotti D; Verzetti G
    Minerva Urol Nefrol; 1991; 43(3):147-52. PubMed ID: 1817337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis.
    Marrs JC; Saseen JJ
    Pharmacotherapy; 2010 Aug; 30(8):823-9. PubMed ID: 20653359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular diseases in dialysis patients].
    Kooman JP; Leunissen KM
    Ned Tijdschr Geneeskd; 1999 May; 143(21):1084-7. PubMed ID: 10368743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia pneumoniae infection and ischemic heart disease in hemodialysis patients.
    Wszola M; Kwiatkowski A; Nosek R; Podsiadly E; Meszaros J; Danielewicz R; Lisik W; Ostrowski K; Chmura A; Adadyński L; Paczek L; Durlik M; Tylewska-Wierzbanowska S; Rowiński W
    Transplant Proc; 2006; 38(1):31-4. PubMed ID: 16504656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Countermeasure for patients with cardiovascular diseases due to hemodialysis].
    Tabei K; Asano Y
    Nihon Naika Gakkai Zasshi; 1995 Oct; 84(10):1678-84. PubMed ID: 8537724
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular problems in chronic renal failure.
    Kotler MN; Segal BL
    Geriatrics; 1984 Jan; 39(1):69-70, 75-7, 81, 84. PubMed ID: 6690369
    [No Abstract]   [Full Text] [Related]  

  • 20. Visit-to-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis: insights from FOSIDIAL.
    Rossignol P; Cridlig J; Lehert P; Kessler M; Zannad F
    Hypertension; 2012 Aug; 60(2):339-46. PubMed ID: 22777936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.